ESMA
European Securities and Markets Authority
ESAs propose EMIR RTS amendment to release initial margin when counterparties fall below the EUR 8bn AANA threshold
Published
Aug 3, 2026
Topics
EMIR, Uncleared OTC derivatives, Initial margin, AANA threshold, Collateral management, EMIR 3, Equity options
Executive Summary
On 3 August 2026, the European Supervisory Authorities published a Final Report containing draft RTS to amend Commission Delegated Regulation (EU) 2016/2251 under EMIR. The proposal targets the initial margin rules for non-centrally cleared OTC derivatives where one of two counterparties has an aggregate month-end average notional amount of uncleared OTC derivatives below EUR 8 billion, calculated using March, April and May. The key regulatory change is relief for existing trades: the derogation from collecting initial margin would no longer be limited to new contracts, and counterparties could release initial margins already collected for outstanding contracts between them. The ESAs also propose that the exemption may be implemented as early as 1 June of the relevant year, while counterparties moving above the threshold would have until no later than 1 January of the following calendar year to apply initial margin to new contracts. The draft is not yet legally binding; it requires European Commission endorsement, scrutiny by Parliament and Council, and publication in the Official Journal.
What Changed
Previous
The Article 28(1) derogation exempted new OTC derivative contracts entered into within a calendar year where one counterparty was below the EUR 8 billion AANA threshold, while existing trades remained subject to initial margin.
New
Under the draft RTS, the derogation would cover all non-centrally cleared OTC derivative contracts between the two counterparties when one counterparty is below the threshold.
Previous
The current RTS did not provide a derogation allowing release of initial margin on existing trades solely because one counterparty later fell below the EUR 8 billion threshold.
New
Under draft Article 28(1)(a)(ii), initial margins collected for outstanding non-centrally cleared OTC derivative contracts between the two counterparties are released.
Previous
Article 28(1) was framed around the calendar year following the AANA calculation for March, April and May of the preceding year.
New
The draft allows the exemption to be implemented as early as 1 June of the same year in which the relevant March-May AANA is below EUR 8 billion.
Previous
The existing framework used the EUR 8 billion AANA threshold to determine whether counterparties became subject to initial margin requirements, with preparation time until the following calendar year.
New
The draft preserves the 1 January following-year deadline for counterparties moving into scope, while specifying application to new contracts between the two counterparties.
Previous
Article 38(1) contained transitional arrangements for single stock equity options and equity index options.
New
The draft deletes Article 38(1), while the exemption for single stock options and equity index options continues under Article 11(3a) of EMIR as amended by Regulation (EU) 2024/2987.
Business Impact
Who is affected
Directly affected
EU EMIR counterparties with non-centrally cleared OTC derivatives whose initial margin status depends on the EUR 8 billion AANA threshold, including financial counterparties and in-scope non-financial counterparties, and groups calculating AANA at counterparty or group level.
Indirectly affected
collateral operations teams, treasury teams, legal documentation teams, risk and compliance functions, custodians, triparty agents, collateral management vendors, and non-EU counterparties trading with EU counterparties.
Jurisdictions
European Union, European Economic Area, given the draft Regulation states text with EEA relevance
Business processes
Annual AANA calculation using March, April and May month-end averages, Initial margin applicability determination by counterparty relationship, Collateral call, dispute and release workflows, Segregated initial margin custody and triparty account management, Legal documentation and collateral schedule review, Counterparty onboarding and annual threshold attestation, Equity option margin-scope classification
Estimated effort
Medium
Compliance risk
Medium
Affected Reports
| Field | Validation rule |
|---|---|
| AANA measurement months | Use aggregate month-end average notional amount of non-centrally cleared OTC derivatives for March, April and May of the given year. |
| AANA threshold | EUR 8 billion determines whether the Article 28(1) initial margin derogation may apply or whether initial margin must apply to new contracts. |
| Counterparty or group calculation level | The aggregate month-end average notional amount is calculated at counterparty level or at group level where the counterparty belongs to a group. |
| Contract population for exemption | Where one counterparty is below the EUR 8 billion threshold, the draft exemption applies to non-centrally cleared OTC derivative contracts between the two counterparties, including outstanding contracts. |
| Initial margin status for outstanding trades | Initial margins collected for outstanding non-centrally cleared OTC derivative contracts between the two counterparties are released where the below-threshold condition is met. |
| Earliest exemption implementation date | Where the below-threshold condition is met, counterparties may implement the exemption as early as 1 June of the relevant year. |
| Latest in-scope implementation date | Where both counterparties exceed the threshold, initial margin requirements must be applied no later than 1 January of the following calendar year for new non-centrally cleared OTC derivative contracts. |
Recommended Actions
- 1AI generatedStep 1 of 7
update annual AANA controls so March-May calculations can support a June decision on whether a counterparty relationship can cease collecting initial margin.
- 2AI generatedStep 2 of 7
create an approval workflow for releasing initial margin on outstanding contracts, including legal, collateral operations and treasury sign-off before any release instruction is sent.
- 3AI generatedStep 3 of 7
review CSAs, custody agreements and triparty arrangements to confirm how optional cessation or release of initial margin can be implemented contractually and operationally.
- 4AI generatedStep 4 of 7
maintain a counterparty-level applicability matrix distinguishing relationships below the threshold, relationships newly above the threshold, and relationships where firms elect to continue collecting initial margin voluntarily.
- 5AI generatedStep 5 of 7
assess liquidity and funding impacts from potential margin release, but also plan for re-entry where both counterparties exceed the threshold and new trades become subject to initial margin by 1 January of the following year.
- 6AI generatedStep 6 of 7
remove reliance on the deleted Article 38(1) transitional logic in internal rule inventories and confirm single stock option and equity index option treatment against EMIR Article 11(3a).
- 7AI generatedStep 7 of 7
monitor the Commission endorsement, Parliament/Council non-objection period and Official Journal publication before treating the draft RTS as binding law.
Timeline
publication
Dec 4, 2024
Regulation (EU) 2024/2987, EMIR 3, was published in the Official Journal and introduced Article 11(3a) into EMIR for single stock options and equity index options not cleared by a CCP.
publication
Aug 3, 2026
The ESAs published the Final Report and submitted draft RTS to the European Commission for endorsement.
implementation
Date not specified
Counterparties calculate AANA for non-centrally cleared OTC derivatives using month-end averages for March, April and May.
implementation
Date not specified
Under the draft RTS, where one counterparty is below EUR 8 billion AANA, counterparties may implement the exemption from initial margin requirements as early as this date.
implementation
Date not specified
Under the draft RTS, where both counterparties are above EUR 8 billion AANA, counterparties must apply initial margin requirements no later than this date for new non-centrally cleared OTC derivative contracts.
effective date
Date not specified
The draft Commission Delegated Regulation would enter into force on this day after Official Journal publication, if endorsed and adopted.
Sources
AI-generated analysis is based on the following primary sources. Always verify against the official publication.
- Final report / draft RTSEuropean Supervisory Authorities / ESMAAug 3, 2026ESAs Final Report: Draft RTS amending Commission Delegated Regulation (EU) 2016/2251 with regard to initial margin requirements applicable to contracts of counterparties that fall below the threshold ↗
https://www.esma.europa.eu/sites/default/files/2026-08/ESA_2026_07_Final_Report_on_amending_RTS_on_uncleared_OTC_derivatives.pdf
- Commission Delegated RegulationEuropean Commission / EUR-LexOct 4, 2016Commission Delegated Regulation (EU) 2016/2251 on risk-mitigation techniques for OTC derivative contracts not cleared by a central counterparty ↗
https://eur-lex.europa.eu/eli/reg_del/2016/2251/oj
- RegulationEuropean Parliament and Council / EUR-LexJul 4, 2012Regulation (EU) No 648/2012 on OTC derivatives, central counterparties and trade repositories ↗
https://eur-lex.europa.eu/eli/reg/2012/648/oj
- RegulationEuropean Parliament and Council / EUR-LexNov 27, 2024Regulation (EU) 2024/2987 amending EMIR as regards excessive exposures to third-country CCPs and the efficiency of Union clearing markets ↗
https://eur-lex.europa.eu/eli/reg/2024/2987/oj
- International standardBCBS and IOSCOApr 2020Margin requirements for non-centrally cleared derivatives ↗
https://www.bis.org/bcbs/publ/d499.pdf
Related Evidence
Verified source support for this analysis
The evidence agent checks whether the drafted finding is supported by official publications and relevant public source material.
Receive updates like this by email
Get AI-generated analysis for the regulators and topics you care about.